Marketing restrictions, platform bans, and the rules governing what an operator is allowed to say.
Aug 12, 2026
A $272 million unsolicited bid meets a special committee. Plus the alcohol industry endorses the hemp beverage bill, and Virginia defends its cap in Roanoke.
Jul 3, 2026
The Senate splits over who regulates hemp, the DOJ names the money behind Schedule I, and a nation founded on the federal-versus-state fight spends its 250th still having it.
Jun 24, 2026
DEA seated only reform's critics for the June 29th hearing, and a standing rule is why. Plus Durrett reads the two-tier order for Nevada, Perris tests cannabis billboard bans at the Ninth Circuit, and Virginia prices public use at $250.
Jun 22, 2026
Inside the Hemani decision and the two ATF rules it now reshapes. Plus Vermont's interstate runway, Missouri moving $71.9M while $95M sits idle, and Colorado teen use at a fresh low.
Jun 17, 2026
An industry-side analysis says the D.C. Circuit could stay and reverse rescheduling if standing clears. Plus the FDA's missing hemp lines, Virginia's market caught in a data-center budget fight, and what rescheduling still hasn't done for banking.
Apr 30, 2026
Oklahoma sets a 60-day clock and Trulieve files first | South Carolina could stumble into a medical program | Indiana's $2 billion border problem travels
Apr 17, 2026
Massachusetts freezes cultivation before dissolution | Virginia reshapes retail | Rand Paul readies a states'-rights hemp bill
Mar 30, 2026
DOJ ghosts Congress on rescheduling. Ohio bans the drink and loses the jobs. Mississippi says no to the patients who need it most.
Mar 19, 2026
Army discipline, Ohio crackdowns, and state infighting all point to the same truth: legalization is still uneven where it matters most.
Mar 12, 2026
Colorado and Massachusetts show what oversupply looks like, while Congress, banks, and states wrestle with the next phase of cannabis policy.
Mar 11, 2026
States move to regulate hemp drinks, courts test enforcement power, and investors react to rescheduling chatter.
Feb 25, 2026
IRS posture stays firm, Virginia and Kentucky accelerate, hemp tightens, and brewers finally quantify what THC is taking.
Feb 20, 2026
Hemp is tightening, retail is shifting, and enforcement is staying loud. Plus Illinois and Washington price compression, Texas distribution, and a reality check on Medicare CBD chatter.
Feb 16, 2026
On Presidents’ Day, executive power meets hemp deadlines, a Massachusetts license freeze, and mounting enforcement pressure across state markets.
Feb 9, 2026
Daily quick briefs start today. We’re tracking FDA deadlines, antitrust risk, revenue pressure, and where enforcement is quietly tightening across markets.
Jan 29, 2026
Massachusetts rewrites market mechanics in conference. DEA chatter needs institutional proof. Oklahoma links illicit grows to cleanup costs and budget muscle.
Jan 23, 2026
Washington rethinks cannabis in care facilities. Congress punts on hemp again. New England politics test market stability.
Jan 22, 2026
Congress dropped the hemp delay, cities move faster than states, and our new essay explains why the two THC markets need rules tightened and relaxed at the same time.
Jan 15, 2026
Why the "corn vs. barley" analogy predicts the future. Plus: Circle K puts hemp in the cold vault, and bankruptcy courts remain off-limits.
Jan 13, 2026
CT targets deal conduct with six-figure fines while NY eyes a potency tax repeal. Texas hemp faces an administrative shutdown. Supported by Wispr Flow and Beehiiv.
Jan 7, 2026
March 2 arguments in Hemani, hemp’s 2026 definition squeeze, DeWine’s late beverage rug pull, plus Florida margin pressure, Virginia hospitals, and UK medical guidance.
Jan 1, 2026
Vermont’s ad settlement brings free speech and marketing restrictions back to the front. The hemp lane stays wider. Plus Schedule III messaging, MA reforms, and hemp age-gating pressure.
Dec 31, 2025
New Year’s Eve edition. Trump’s Schedule III push heads toward publication and court, while Congress’ hemp THC crackdown forces product and channel decisions for 2026.
Dec 22, 2025
The headline was easy. The effective date will be hard. Schedule III now lives in rulemaking, litigation risk, and state pushback, plus fresh moves in Ohio, New York, and 2026 ballot politics.
Dec 17, 2025
Trump weighs a faster Schedule III route, banks stay cautious, and hemp fights for standards before the ban bites.
